CLINCH VALLEY MEDICAL CENTER
1. Target Overview & Investment Thesis
CLINCH VALLEY MEDICAL CENTER is a 151-bed suburban community hospital in TAZEWELL, VA with $123.5M in net patient revenue and a 5.1% operating margin. The hospital serves a payer mix of 28.3% Medicare, 1.3% Medicaid, and 70.4% commercial.
Thesis: Turnaround. Our ML models identify $9.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 5.1% to 12.4% (+736bps).
| Net Revenue HCRIS | $123.5M |
| Current EBITDA COMPUTED | $6.3M |
| Operating Margin COMPUTED | 5.1% |
| Occupancy HCRIS | 21.2% |
| Revenue / Bed COMPUTED | $818K |
| Net-to-Gross HCRIS | 17.6% |
| Distress Probability ML | 53.5% |
2. Market Context & Competitive Position
VA has 111 Medicare-certified hospitals with a median operating margin of 4.4%. The target's margin of 5.1% places it above the state median. Among 46 size-comparable peers (76-302 beds), the median margin is 5.6%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (76-302), prioritizing same-state peers. 46 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CLINCH VALLEY MEDICAL CENTER (Target) | VA | 151 | $123.5M | 5.1% |
| CHILDRENS HOSPITAL OF THE KING | VA | 202 | $546.2M | -9.9% |
| SENTARA LEIGH HOSPITAL | VA | 274 | $511.5M | 14.7% |
| INOVA LOUDOUN HOSPITAL CENTER | VA | 189 | $510.3M | 22.9% |
| SENTARA VA. BEACH GENERAL HOSP | VA | 239 | $443.9M | 15.2% |
| SENTARA RMH MEDICAL CENTER | VA | 238 | $408.3M | -22.8% |
| AUGUSTA MEDICAL CENTER | VA | 223 | $401.1M | 6.0% |
| CHESAPEAKE GENERAL HOSPITAL | VA | 302 | $398.1M | 0.9% |
| MEMORIAL REGIONAL MEDICAL CENT | VA | 243 | $389.5M | -3.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.1M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.6M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.5M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.4M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.5M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $79K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $6.3M |
| + RCM Uplift | +$9.1M |
| Pro Forma EBITDA | $15.4M |
| Current Margin | 5.1% |
| Pro Forma Margin | 12.4% |
| WC Released (1x) | $4.7M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $9.6M | $132.2M | 13.72x | 68.8% |
| Base (11x exit) | 10.0x | 11.0x | $9.6M | $148.6M | 15.42x | 72.8% |
| Bull Case | 9.0x | 11.0x | $8.7M | $181.7M | 20.95x | 83.8% |
| Bull (12x exit) | 9.0x | 12.0x | $8.7M | $200.8M | 23.15x | 87.5% |
| Bear Case | 11.0x | 10.0x | $10.6M | $83.6M | 7.89x | 51.2% |
| Bear (11x exit) | 11.0x | 11.0x | $10.6M | $95.4M | 9.01x | 55.2% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Low occupancy | At 21.2%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 53.5% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 46 hospitals with 76-302 beds
- Same-state prioritization (n=47)
- Comp margins: P25=-4.8% / P50=5.6% / P75=15.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.